FMP
Achieve Life Sciences, Inc.
ACHV
NASDAQ
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
3.69 USD
-0.13 (-3.52%)
We are unable to load the chart at this time.
Dr. Richard A. B. Stewart
Healthcare
Biotechnology
NASDAQ
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
0000949858
US0044685008
004468203
1040 West Georgia Street
14256861500
CA
22
Oct 12, 1995
We are unable to load the chart at this time.
We are unable to load the chart at this time.
0000949858
NASDAQ
Biotechnology
Healthcare
004468203
US0044685008
CA
3.69
1.58
116.76k
126.9M
-
3.41-5.59
-0.06
-
-
-
-
-3.29
-
https://www.achievelifesciences.com
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.